Rubin Tan

1.1k total citations · 2 hit papers
29 papers, 605 citations indexed

About

Rubin Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Rubin Tan has authored 29 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Rubin Tan's work include Pulmonary Hypertension Research and Treatments (7 papers), Mitochondrial Function and Pathology (6 papers) and Cancer-related molecular mechanisms research (6 papers). Rubin Tan is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), Mitochondrial Function and Pathology (6 papers) and Cancer-related molecular mechanisms research (6 papers). Rubin Tan collaborates with scholars based in China, United States and Canada. Rubin Tan's co-authors include Jinxiang Yuan, Shijun Wang, Qian Liu, Jian Wu, Fei Gao, Xin Liu, Hui Meng, Meng Zhang, Qinghua Hu and Yue Shi and has published in prestigious journals such as Free Radical Biology and Medicine, Hypertension and Cellular and Molecular Life Sciences.

In The Last Decade

Rubin Tan

28 papers receiving 591 citations

Hit Papers

Ischemia-reperfusion injury: molecular mechanisms and the... 2024 2026 2025 2024 2025 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rubin Tan China 11 249 127 80 65 53 29 605
Pingping Chen China 13 265 1.1× 99 0.8× 57 0.7× 60 0.9× 29 0.5× 73 609
Yaqi Zhou China 15 294 1.2× 63 0.5× 107 1.3× 57 0.9× 72 1.4× 44 651
Chi Liu China 15 411 1.7× 80 0.6× 100 1.3× 77 1.2× 61 1.2× 39 834
Natthaphat Siri‐Angkul Thailand 14 318 1.3× 126 1.0× 70 0.9× 66 1.0× 26 0.5× 30 682
Romina Tripaldi Italy 14 269 1.1× 107 0.8× 71 0.9× 93 1.4× 22 0.4× 28 876
Yanqin Fan China 11 340 1.4× 165 1.3× 134 1.7× 51 0.8× 29 0.5× 18 628

Countries citing papers authored by Rubin Tan

Since Specialization
Citations

This map shows the geographic impact of Rubin Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubin Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubin Tan more than expected).

Fields of papers citing papers by Rubin Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rubin Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubin Tan. The network helps show where Rubin Tan may publish in the future.

Co-authorship network of co-authors of Rubin Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Rubin Tan. A scholar is included among the top collaborators of Rubin Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rubin Tan. Rubin Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Kai, Hongyun Jia, Ying Lu, et al.. (2025). Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies. Biomedicines. 13(2). 327–327. 19 indexed citations breakdown →
2.
Adu‐Amankwaah, Joseph, Xinying Liu, Jiayi Jiang, et al.. (2025). Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies. MedComm. 6(3). e70134–e70134. 5 indexed citations
3.
Shi, Yue, Yixuan Ma, Xinying Liu, et al.. (2025). HMGB1: a multifaceted mediator of cell death pathways in cardiovascular diseases. APOPTOSIS. 30(11-12). 2612–2634.
4.
Adu‐Amankwaah, Joseph, Adebayo Oluwafemi Adekunle, Ziqing Tang, et al.. (2024). Estradiol contributes to sex differences in resilience to sepsis-induced metabolic dysregulation and dysfunction in the heart via GPER-1-mediated PPARδ/NLRP3 signaling. Metabolism. 156. 155934–155934. 14 indexed citations
5.
Adu‐Amankwaah, Joseph, et al.. (2024). Decoding long non‑coding RNAs: Friends and foes in cancer development (Review). International Journal of Oncology. 64(6). 2 indexed citations
6.
Adu‐Amankwaah, Joseph, et al.. (2024). Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms. Heliyon. 10(5). e27207–e27207. 7 indexed citations
7.
Meng, Kai, Wenjie Qin, Mingchao Jiang, et al.. (2024). Mechanism of mitochondrial oxidative phosphorylation disorder in male infertility. Chinese Medical Journal. 138(4). 379–388. 8 indexed citations
8.
Adekunle, Adebayo Oluwafemi, Joseph Adu‐Amankwaah, Rubin Tan, et al.. (2024). CD73/adenosine axis exerts cardioprotection against hypobaric hypoxia-induced metabolic shift and myocarditis in a sex-dependent manner. Cell Communication and Signaling. 22(1). 166–166. 2 indexed citations
9.
Zhang, Meng, Qian Liu, Hui Meng, et al.. (2024). Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduction and Targeted Therapy. 9(1). 12–12. 280 indexed citations breakdown →
10.
Adu‐Amankwaah, Joseph, Rubin Tan, Adebayo Oluwafemi Adekunle, et al.. (2023). Estradiol mitigates stress-induced cardiac injury and inflammation by downregulating ADAM17 via the GPER-1/PI3K signaling pathway. Cellular and Molecular Life Sciences. 80(9). 246–246. 14 indexed citations
11.
Wang, Hao, Yibo Wang, Yifei Dai, et al.. (2023). p53 contributes to cardiovascular diseases via mitochondria dysfunction: A new paradigm. Free Radical Biology and Medicine. 208. 846–858. 21 indexed citations
13.
Tan, Rubin, et al.. (2022). Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension. Frontiers in Cardiovascular Medicine. 9. 945854–945854. 5 indexed citations
14.
Wang, Haiying, Ran Zhang, Yafen Chen, et al.. (2022). Programmed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22K Mice via Inhibition of PKC-α/NFAT Pathway. Frontiers in Cardiovascular Medicine. 9. 808163–808163. 5 indexed citations
15.
Fang, Hui, Yiming Zhang, Joseph Adu‐Amankwaah, et al.. (2022). Applications and challenges of rhodopsin-based optogenetics in biomedicine. Frontiers in Neuroscience. 16. 966772–966772. 14 indexed citations
16.
Tan, Rubin, Jie Cui, Mingming Wang, et al.. (2022). Sodium houttuyfonate against cardiac fibrosis attenuates isoproterenol-induced heart failure by binding to MMP2 and p38. Phytomedicine. 109. 154590–154590. 8 indexed citations
17.
Tan, Rubin, Li Cui, Chuan Xu, et al.. (2021). Targeting JP2: A New Treatment for Pulmonary Hypertension. Oxidative Medicine and Cellular Longevity. 2021(1). 2003446–2003446. 5 indexed citations
18.
Tan, Rubin, Jiansha Li, Matthieu Ruiz, et al.. (2020). Phenylalanine induces pulmonary hypertension through calcium-sensing receptor activation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 319(6). L1010–L1020. 27 indexed citations
19.
Tan, Rubin, Jiansha Li, Xiaochun Peng, et al.. (2013). GAPDH is critical for superior efficacy of female bone marrow-derived mesenchymal stem cells on pulmonary hypertension. Cardiovascular Research. 100(1). 19–27. 20 indexed citations
20.
Hindle, William H., et al.. (1970). Pleural Effusion and Fibrosis during Treatment with Methysergide. BMJ. 1(5696). 605–606. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026